What is Solix Algredients?
Headquartered in Fort Collins, Colorado, Solix Algredients operates as a specialized B2B supplier focused on the production of natural, algae-based ingredients. The company leverages its deep expertise in algal cultivation to manufacture premium products, including Solasta Astaxanthin and Solmega DHA Omega-3. By maintaining a robust supply chain, Solix serves the health-conscious consumer market, providing essential nutrients that meet the rising demand for sustainable and plant-based alternatives. Their market position is defined by a proven ability to demonstrate technology at scale, distinguishing them from early-stage competitors in the biotech space.
How much funding has Solix Algredients raised?
Solix Algredients has raised a total of $223.1M across 5 funding rounds:
Series A
$168M
Unspecified
$6.1M
Unspecified
$2M
Series B
$16M
Series C
$31M
Series A (2009): $168M with participation from Southern Ute, Valero Energy, I2BF Venture Capital, Infield Capital, and Shanghai Alliance Investment Ltd.
Unspecified (2009): $6.1M led by I2BF Global Ventures
Unspecified (2010): $2M, investors not publicly disclosed
Series B (2011): $16M featuring I2BF Global Ventures
Series C (2012): $31M backed by Southern Ute and I2BF Global Ventures
Key Investors in Solix Algredients
I2BF Global Ventures
A venture capital firm focused on investing in high-growth technology companies, with a particular emphasis on sustainable energy and industrial biotechnology sectors.
Southern Ute
An investment entity associated with the Southern Ute Indian Tribe, known for its diversified portfolio and strategic interest in energy and natural resource-based enterprises.
Valero Energy
A Fortune 500 international manufacturer and marketer of transportation fuels and petrochemical products, often exploring sustainable energy and feedstock innovations.
What's next for Solix Algredients?
With the support of its latest strategic financing, Solix Algredients is well-positioned to optimize its production capabilities and expand its market reach. The company's forward-looking strategy likely involves deepening its penetration into the global nutraceutical and functional food sectors, where demand for high-purity algal ingredients continues to accelerate. By focusing on operational efficiency and the commercialization of its core product portfolio, Solix aims to capitalize on the growing shift toward natural, science-backed health solutions. Future growth will likely be driven by continued innovation in cultivation techniques and the strengthening of strategic partnerships within the global supply chain.
See full Solix Algredients company page
